By Varun Saxena The FDA slapped Smith & Nephew ($SNN) with a warning letter for quality-control violations at its Andover, MA, facility related to problems with some of the company’s mechanical morcellators for removal of intrauterine tissue. The company has

Share on LinkedInShare on FacebookShare on Google+Pin on PinterestEmail this to someone